ISSUES INVOLVED IN THE FINANCING OF CANADIAN BIOTECHNOLOGY FIRMS BY VENTURE CAPITALISTS

Authors:

Abstract
What are Canadian venture capitalists looking for when they evaluate financing proposals from Canadian biotechnology firms? This paper reports the findings from a study that investigated this question by surveying members of the Association of Canadian Venture Capital Companies. The objective of the study was to identify those concerns which biotechnology firms might address to obtain the venture-capital financing that is sorely needed. The results indicate that venture capitalists are most interested in financing late, rather than early, stage firms. In addition, they approach biotechnology investments in much the same way as other investments, heavily weighing the personal qualities and experience of the entrepreneur, the presence of a balanced management team, and the existence of strong business and management skills. However, they perceive these competencies to be largely missing from Canadian biotechnology firms at present.

This publication has 8 references indexed in Scilit: